In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.
暂无分享,去创建一个
Chunlong Ma | Jun Wang | Yanmei Hu | Yuanxiang Wang | Shuting Xu | Raymond K Hau | R. Musharrafieh | Yongtao Zhang | Raymond K. Hau | Rami Musharrafieh